IGFBP5 and breast cancer: Using cDNA and tissue microarray technologies, we and others have found that IGFBP5 overexpression is associated with a poor prognosis and with metastasis in patients with breast cancer [16-19]; however, the mechanism by which IGFBP5 promotes metastasis is unknown.